Brandes Investment Partners’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Brandes Investment Partners’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-34,000	Closed	-$58K	–	207
2015 Q2	$58K	Hold	34,000	–	–	﹤0.01%	179
2015 Q1	$72K	Buy	+34,000	New	+$79.7K	﹤0.01%	165

Other funds holding ECTE

Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EEG

E.E. Geduld $178M AUM 29.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Brandes Investment Partners's ECTE Position: Q3 2015 in Review

Brandes Investment Partners sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2015, closing a stake of 34,000 shares — an estimated $58K sold.

Brandes Investment Partners first reported a position in ECTE in Q1 2015 and held it in 2 quarters. The position peaked at $72K in Q1 2015. 18 funds tracked by Wall St. Rank hold ECTE as of Q3 2015.

Brandes Investment Partners reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2015 after selling out during the quarter.
Brandes Investment Partners sold 34,000 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2015, an estimated $58K.
Brandes Investment Partners first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q1 2015 and held it in 2 quarters.
Brandes Investment Partners's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $72K in Q1 2015.
18 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2015.

Based on Brandes Investment Partners's 13F filing for Q3 2015, filed 6 Nov 2015.